Literature DB >> 16876338

Effect of chronic FIV infection, and efficacy of marbofloxacin treatment, on Mycoplasma haemofelis infection.

Séverine Tasker1, Sarah M A Caney, Michael J Day, Rachel S Dean, Chris R Helps, Toby G Knowles, Philippa J P Lait, Mark D G Pinches, Timothy J Gruffydd-Jones.   

Abstract

The purpose of this study was to investigate the effect of chronic feline immunodeficiency virus (FIV) infection, and efficacy of marbofloxacin treatment, on Mycoplasma haemofelis infection. Six cats chronically infected with FIV-Glasgow8 (Group X) and six FIV-free cats (Group Y) were infected with M. haemofelis on Day 0 by intravenous blood inoculation. From Day 0 until Day 86 post-infection (pi), blood samples were collected for M. haemofelis and FIV provirus quantitative real-time PCR and haematology. Three of the six cats in each of Groups X and Y were randomly selected to receive marbofloxacin treatment (2 mg/kg PO q24 h) from Day 16 to 43 pi, with the remaining cats being untreated controls with no antibiotic treatment. The M. haemofelis copy numbers and haematological data were compared between Groups X and Y, and between marbofloxacin-treated and control cats using a Mann-Whitney U-test. M. haemofelis infection was associated with development of macrocytic hypochromic anaemia. In some cats, marked variation in M. haemofelis copy number over time (>100,000-fold difference within 48 h in some cats) and/or cycling of copy number was seen. No correlation was found between FIV provirus copy number and M. haemofelis copy number or haematological variables. No significant effect of chronic FIV infection on M. haemofelis copy number kinetics or haematological changes due to M. haemofelis infection was found, other than MCHC (P=0.03). Marbofloxacin treatment was associated with a significant decrease in M. haemofelis copy number (P=0.002), although consistent clearance of infection was not demonstrated. This study reveals the presence of marked fluctuations in M. haemofelis copy number kinetics in vivo and a significant response to marbofloxacin antibiotic treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16876338     DOI: 10.1016/j.vetmic.2006.06.015

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  20 in total

1.  Detection of humoral response using a recombinant heat shock protein 70, DnaK, of Mycoplasma haemofelis in experimentally and naturally hemoplasma-infected cats.

Authors:  Emily N Barker; Chris R Helps; Kate J Heesom; Christopher J Arthur; Iain R Peters; Regina Hofmann-Lehmann; Séverine Tasker
Journal:  Clin Vaccine Immunol       Date:  2010-10-06

2.  Identification, characterization, and application of a recombinant antigen for the serological investigation of feline hemotropic Mycoplasma infections.

Authors:  Godelind A Wolf-Jäckel; Christian Jäckel; Kristina Museux; Katharina Hoelzle; Séverine Tasker; Hans Lutz; Regina Hofmann-Lehmann
Journal:  Clin Vaccine Immunol       Date:  2010-09-28

3.  Anemia in cats with hemotropic mycoplasma infection: retrospective evaluation of 23 cases (1996-2005).

Authors:  Belle Marie D Nibblett; Elisabeth C Snead; Cheryl Waldner; Susan M Taylor; Marion L Jackson; Laina M Knorr
Journal:  Can Vet J       Date:  2009-11       Impact factor: 1.008

4.  Complete genome sequence of Mycoplasma haemofelis, a hemotropic mycoplasma.

Authors:  Emily N Barker; Chris R Helps; Iain R Peters; Alistair C Darby; Alan D Radford; Séverine Tasker
Journal:  J Bacteriol       Date:  2011-02-11       Impact factor: 3.490

5.  Worldwide occurrence of feline hemoplasma infections in wild felid species.

Authors:  Barbara Willi; Claudia Filoni; José L Catão-Dias; Valentino Cattori; Marina L Meli; Astrid Vargas; Fernando Martínez; Melody E Roelke; Marie-Pierre Ryser-Degiorgis; Christian M Leutenegger; Hans Lutz; Regina Hofmann-Lehmann
Journal:  J Clin Microbiol       Date:  2007-02-14       Impact factor: 5.948

Review 6.  Haemotropic mycoplasmas: what's their real significance in cats?

Authors:  Séverine Tasker
Journal:  J Feline Med Surg       Date:  2010-05       Impact factor: 2.015

7.  "Candidatus Mycoplasma haemomacaque" and Bartonella quintana bacteremia in cynomolgus monkeys.

Authors:  Ricardo G Maggi; Patricia E Mascarelli; Nandhakumar Balakrishnan; Cynthia M Rohde; Catherine M Kelly; Lila Ramaiah; Michael W Leach; Edward B Breitschwerdt
Journal:  J Clin Microbiol       Date:  2013-02-13       Impact factor: 5.948

8.  Development and application of a universal Hemoplasma screening assay based on the SYBR green PCR principle.

Authors:  Barbara Willi; Marina L Meli; Ruedi Lüthy; Hanspeter Honegger; Nicole Wengi; Ludwig E Hoelzle; Claudia E Reusch; Hans Lutz; Regina Hofmann-Lehmann
Journal:  J Clin Microbiol       Date:  2009-10-14       Impact factor: 5.948

9.  Description of outcomes of experimental infection with feline haemoplasmas: copy numbers, haematology, Coombs' testing and blood glucose concentrations.

Authors:  Séverine Tasker; Iain R Peters; Kostas Papasouliotis; Simon M Cue; Barbara Willi; Regina Hofmann-Lehmann; Timothy J Gruffydd-Jones; Toby G Knowles; Michael J Day; Chris R Helps
Journal:  Vet Microbiol       Date:  2009-06-21       Impact factor: 3.293

10.  Distribution of Mycoplasma haemofelis in blood and tissues following experimental infection.

Authors:  Séverine Tasker; Iain R Peters; Michael J Day; Barbara Willi; Regina Hofmann-Lehmann; Timothy J Gruffydd-Jones; Chris R Helps
Journal:  Microb Pathog       Date:  2009-09-23       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.